Abstract:Regulatory T cells (Tregs) are critical for generating and maintaining peripheral tolerance. Treg-based immunotherapy is valuable for the clinical management of diseases resulting from dysregulation of immune tolerance. However, the lack of potency is a potential limitation of Treg therapy. In addition, CD69 positive-Treg (CD69+ Treg) represent a newly identified subset of Tregs with potent immune suppressive capability. Methods: Foxp3 YFP-Cre CD69 fl/fl and CD4 Cre CD69 fl/fl mice were generated to determine the relevance of CD69 to Treg. Chromatin Immunoprecipitation Assay (ChIP) and luciferase Assay were performed to detect the regulation of CD69 transcription by heat shock transcription factor 1(HSF1). Gene expression was measured by western blotting and qRT-PCR. The differentiation of naive T cells to CD69+Foxp3+ iTregs was determined by flow cytometry. The immunosuppressive ability of Tregs was analyzed by ELISA and flow cytometry. Colon inflammation in mice was reflected by changes in body weight and colon length, the disease activity index (DAI), and H&E staining of colon tissues. Results: Induced Tregs (iTregs) from CD4 Cre CD69 fl/fl mice failed to alleviate colitis. The transcription factor HSF1 interacted with the promoter of the CD69 gene to prompt its transcription during Treg differentiation. Genetic and chemical inhibition of HSF1 impaired CD69+ Treg differentiation and promoted the pathogenesis of colitis in mice. In contrast, HSF1 protein stabilized by inhibiting its proteasomal degradation promoted CD69+ Treg differentiation and alleviated colitis in mice. Moreover, adoptive transfer of iTregs with HSF1 stabilization by proteasome inhibitor (PSI) dramatically prevented the development of colitis in mice and was accompanied by decreased production of pro-inflammatory cytokines and reduced accumulation of pro-inflammatory lymphocytes in colitis tissue, whereas Tregs induced in the absence of PSI were less stable and ineffective in suppressing colitis. Conclusions: HSF1 promotes CD69+ Tregs differentiation by activating the CD69 transcription, which is critical for the immunosuppressive function of Tregs. Stabilization of HSF1 by PSIs results in the efficient generation of Tregs with high potency to treat colitis and probably other autoimmune diseases involving Tregs deficiency.

CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production

Tgf-Beta-Induced Regulatory T Cells Directly Suppress B Cell Responses Through A Noncytotoxic Mechanism

HSF1 promotes CD69+ Treg differentiation to inhibit colitis progression

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

TGF-|[bgr]|1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4|[plus]|Foxp3|[plus]| regulatory T cells

Essential Roles Of Tgf-Beta In Anti-Cd3 Antibody Therapy: Reversal Of Diabetes In Nonobese Diabetic Mice Independent Of Foxp3(+) Cd4(+) Regulatory T Cells

Recovery of CD226-TIGIT+FoxP3+ and CD226-TIGIT-FoxP3+ Regulatory T Cells Contributes to Clinical Remission from Active Stage in Ulcerative Colitis Patients

Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease

Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice

Anti-mouse CD52 Treatment Ameliorates Colitis Through Suppressing Th1/17 Mediated Inflammation and Promoting Tregs Differentiation in IL-10 Deficient Mice

Foxp3-expressing CD4+T Cells under the Control of IFN-γ Promoter Prevent Diabetes in NOD Mice

Interaction of Cd5 and Cd72 is Involved in Regulatory T and B Cell Homeostasis

Foxd3 Suppresses Interleukin-10 Expression in B Cells.

TGF-β1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4 + Foxp3 + regulatory T cells

Critical Role for Thymic CD19+CD5+CD1dhiIL-10+ Regulatory B Cells in Immune Homeostasis.

Therapeutic Potential of TGF-β-induced CD4+ Foxp3+ Regulatory T Cells in Autoimmune Diseases

Blockade of IL-18 signaling downregulates homing of effector CD4+ T cells to the gut mucosa and provides protection from experimental IBD

Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of T H 17 cell immunity

IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites

Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1

The Molecular Mechanisms of Regulatory T Cell Immunosuppression